Skip to Main Content

Author Details

Yonatan H Grad
Harvard T H Chan School of Public Health, Harvard University
2002
143
42
PMIDPaper TitleJournal TitlePublished Year
37883986Estimating changes in antibiotic consumption in the USA with the introduction of doxycycline post-exposure prophylaxis.Lancet Microbe2024
37625444The Impact of Rapid Drug Susceptibility Tests on Gonorrhea Burden and the Life Span of Antibiotic Treatments: A Modeling Study Among Men Who Have Sex With Men in the United States.Am J Epidemiol2024
34913422Post-discharge decolonization of patients harboring methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) USA300 strains: secondary analysis of the CLEAR Trial.Infect Control Hosp Epidemiol2023
38014331Spatiotemporal Trends in Group A Streptococcal Pharyngitis in the United States.medRxiv2023
37798265Viral kinetics of sequential SARS-CoV-2 infections.Nat Commun2023
37902472The "Bubble": What Can Be Learned from the National Basketball Association (NBA)'s 2019-20 Season Restart in Orlando during the COVID-19 Pandemic.J Appl Lab Med2023
37790567Estimating changes in antibiotic consumption with the introduction of doxycycline post-exposure prophylaxis in the United States.medRxiv2023
37619582Resistance-minimising strategies for introducing a novel antibiotic for gonorrhoea treatment: a mathematical modelling study.Lancet Microbe2023
35706396Epidemiology and genomics of a slow outbreak of methicillin-resistant <i>Staphyloccus aureus</i> (MRSA) in a neonatal intensive care unit: Successful chronic decolonization of MRSA-positive healthcare personnel.Infect Control Hosp Epidemiol2023
36993406A genomic perspective on the near-term impact of doxycycline post-exposure prophylaxis on <i>Neisseria gonorrhoeae</i> antimicrobial resistance.medRxiv2023
37312496Estimating the fitness cost and benefit of antimicrobial resistance from pathogen genomic data.J R Soc Interface2023
37212677O-Antigen Diversification Masks Identification of Highly Pathogenic Shiga Toxin-Producing Escherichia coli O104:H4-Like Strains.Microbiol Spectr2023
37081443Projecting the development of antimicrobial resistance in Neisseria gonorrhoeae from antimicrobial surveillance data: a mathematical modelling study.BMC Infect Dis2023
37236213Neisseria gonorrhoeae ciprofloxacin susceptibility testing and gyrA targets - Authors' reply.Lancet Microbe2023
37138444A Genomic Perspective on the Near-term Impact of Doxycycline Post-exposure Prophylaxis on Neisseria gonorrhoeae Antimicrobial Resistance.Clin Infect Dis2023
37162882Resistance and prevalence implications of doxycycline post-exposure prophylaxis for gonorrhea prevention in men who have sex with men: a modeling study.medRxiv2023
36882240Geographically skewed recruitment and COVID-19 seroprevalence estimates: a cross-sectional serosurveillance study and mathematical modelling analysis.BMJ Open2023
36692583Generating simple classification rules to predict local surges in COVID-19 hospitalizations.Health Care Manag Sci2023
36573759Machine learning models for Neisseria gonorrhoeae antimicrobial susceptibility tests.Ann N Y Acad Sci2023
36604513CanB is a metabolic mediator of antibiotic resistance in Neisseria gonorrhoeae.Nat Microbiol2023
36868257Neisseria gonorrhoeae diagnostic escape from a gyrA-based test for ciprofloxacin susceptibility and the effect on zoliflodacin resistance: a bacterial genetics and experimental evolution study.Lancet Microbe2023
36735316Whole-Genome Sequencing to Predict Antimicrobial Susceptibility Profiles in Neisseria gonorrhoeae.J Infect Dis2023
36196577Impact of Respiratory Infection and Chronic Comorbidities on Early Pediatric Antibiotic Dispensing in the United States.Clin Infect Dis2023
34453431Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Series From a 12-Month Longitudinal Occupational Cohort.Clin Infect Dis2022
35653123Association Between COVID-19 Booster Vaccination and Omicron Infection in a Highly Vaccinated Cohort of Players and Staff in the National Basketball Association.JAMA2022
35736134Characterizing SARS-CoV-2 Viral Clearance Kinetics to Improve the Design of Antiviral Pharmacometric Studies.Antimicrob Agents Chemother2022
35544098Loci for prediction of penicillin and tetracycline susceptibility in Neisseria gonorrhoeae: a genome-wide association study.Lancet Microbe2022
35702866Modelling methicillin-resistant <i>Staphylococcus aureus</i> decolonization: interactions between body sites and the impact of site-specific clearance.J R Soc Interface2022
35471082Sculpting the Bacterial <i>O</i>-Glycoproteome: Functional Analyses of Orthologous Oligosaccharyltransferases with Diverse Targeting Specificities.mBio2022
35452084ANTICIPATING RACIAL/ETHNIC MORTALITY DISPLACEMENT FROM COVID-19.Am J Epidemiol2022
36601300Discovering recent selection forces shaping the evolution of dengue viruses based on polymorphism data across geographic scales.Virus Evol2022
36383192Quantifying the impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound: A retrospective cohort study.Elife2022
36191537Optimizing prevalence estimates for a novel pathogen by reducing uncertainty in test characteristics.Epidemics2022
35213690Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence in Massachusetts Estimated from Newborn Screening Specimens.Clin Infect Dis2022
35139073Evaluating spatially adaptive guidelines for the treatment of gonorrhea to reduce the incidence of gonococcal infection and increase the effective lifespan of antibiotics.PLoS Comput Biol2022
35263322Analysis of multiple bacterial species and antibiotic classes reveals large variation in the association between seasonal antibiotic use and resistance.PLoS Biol2022
32173727Distinguishing the Roles of Antibiotic Stewardship and Reductions in Outpatient Visits in Generating a 5-Year Decline in Antibiotic Prescribing.Clin Infect Dis2021
33795856Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination.Nat Rev Immunol2021
33903899Childhood Respiratory Outpatient Visits Correlate With Socioeconomic Status and Drive Geographic Patterns in Antibiotic Prescribing.J Infect Dis2021
33875000A community-driven resource for genomic epidemiology and antimicrobial resistance prediction of Neisseria gonorrhoeae at Pathogenwatch.Genome Med2021
33786582Reduction in Antibiotic Prescribing Attainable With a Gonococcal Vaccine.Clin Infect Dis2021
33564784Recruitment location influences bias and uncertainty in SARS-CoV-2 seroprevalence estimates.medRxiv2021
33785063Emergence and evolution of antimicrobial resistance genes and mutations in Neisseria gonorrhoeae.Genome Med2021
33885715SARS-CoV-2 Transmission Risk Among National Basketball Association Players, Staff, and Vendors Exposed to Individuals With Positive Test Results After COVID-19 Recovery During the 2020 Regular and Postseason.JAMA Intern Med2021
34941024Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons.N Engl J Med2021
34252080Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.PLoS Biol2021
34245280Identification of bile acid and fatty acid species as candidate rapidly bactericidal agents for topical treatment of gonorrhoea.J Antimicrob Chemother2021
34339241Evidence Of Respiratory Infection Transmission Within Physician Offices Could Inform Outpatient Infection Control.Health Aff (Millwood)2021
33330882Model-informed COVID-19 vaccine prioritization strategies by age and serostatus.medRxiv2021
33479118Model-informed COVID-19 vaccine prioritization strategies by age and serostatus.Science2021
  • 1 - 50 of 143

Recommended Authors

Yale School of Public Health, YaleUniversity
Career Start Year 2015
Number of shared co-authors 5
McGill University
Career Start Year 2014
Number of shared co-authors 0
US Centers for Disease Control and Prevention
Career Start Year 2013
Number of shared co-authors 0
Institute for Genome Sciences, University of Maryland School of Medicine
Career Start Year 2013
Number of shared co-authors 0
Washington University School of Medicine
Career Start Year 2012
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2012
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 2011
Number of shared co-authors 6
Center for International Health, University of Maryland School of Medicine
Career Start Year 2011
Number of shared co-authors 3
University of Washington Medical Center
Career Start Year 2008
Number of shared co-authors 7
Centers for Disease Control and Prevention
Career Start Year 2006
Number of shared co-authors 6
University of Virginia Health System. Charlottesville
Career Start Year 2006
Number of shared co-authors 0
Institute of Medical Virology, University of Zurich
Career Start Year 2006
Number of shared co-authors 2
Stanford University
Career Start Year 2006
Number of shared co-authors 2
University of California, Davis Center for Valley Fever
Career Start Year 2005
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 2005
Number of shared co-authors 1
Fred Hutchinson Cancer Center
Career Start Year 2004
Number of shared co-authors 4
Emory University School of Medicine
Career Start Year 2004
Number of shared co-authors 2
Karolinska Institutet
Career Start Year 2004
Number of shared co-authors 0
Yale University School of Medicine
Career Start Year 2002
Number of shared co-authors 8
F.I. Proctor Foundation, University of California san francisco
Career Start Year 2001
Number of shared co-authors 0
Vitalant Research Institute, USA University of California san francisco
Career Start Year 2001
Number of shared co-authors 0
Children's Healthcare of Atlanta and Emory University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
National Centre for Infectious Diseases
Career Start Year 1998
Number of shared co-authors 1
University of Birmingham
Career Start Year 1998
Number of shared co-authors 10
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1994
Number of shared co-authors 0
United States Zucker School of Medicine at Hofstra/Northwell
Career Start Year 1992
Number of shared co-authors 1
Centers for Disease Control and Prevention
Career Start Year 1991
Number of shared co-authors 0
University of California-San Francisco
Career Start Year 1991
Number of shared co-authors 7
University of Utah
Career Start Year 1987
Number of shared co-authors 0
University of California berkeley
Career Start Year 1971
Number of shared co-authors 0

Collaborators

Yale School of Public Health
Co-authored papers 5
University of Nebraska Medical Center
Co-authored papers 5
Harvard Medical School
Co-authored papers 4
Johns Hopkins University School of Medicine, The Johns Hopkins Hospital
Co-authored papers 4
Broad Institute of MIT and Harvard
Co-authored papers 4
Broad Institute of MIT and Harvard
Co-authored papers 3
Broad Institute of MIT and Harvard
Co-authored papers 3
Massachusetts General Hospital/Harvard Medical School
Co-authored papers 2
Harvard University
Co-authored papers 2
Institute for Next Generation Healthcare
Co-authored papers 2
Vanderbilt-Ingram Cancer Center, Vanderbilt University
Co-authored papers 2
Broad Institute of Harvard and MIT
Co-authored papers 2
Co-authored papers 2
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 2
Massachusetts General Hospital
Co-authored papers 2
Co-authored papers 2
Institute of Technology, Broad Institute of Harvard and Massachusetts
Co-authored papers 2
Harvard T.H. Chan School of Public Health
Co-authored papers 1
Co-authored papers 1
Massachusetts General Hospital, Harvard Medical School
Co-authored papers 1
Co-authored papers 1
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Broad Institute of MIT and Harvard
Co-authored papers 1
King's College London
Co-authored papers 1
Yale School of Public Health
Co-authored papers 1
ETH Zurich
Co-authored papers 1
University of Colorado Anschutz School of Medicine
Co-authored papers 1
Weizmann Institute of Science
Co-authored papers 1